Denovo Biopharma
CompanyROR
Trials
Phase 2/3, Terminated, 560 people, 25 May 2010
Phase 2, Completed, 261 people, 16 Feb 2009
Phase 2, Completed, 669 people, 27 Aug 2007
Phase 2, Completed, 195 people, 8 Sept 2005
CompanyROR
Phase 2/3, Terminated, 560 people, 25 May 2010
Phase 2, Completed, 261 people, 16 Feb 2009
Phase 2, Completed, 669 people, 27 Aug 2007
Phase 2, Completed, 195 people, 8 Sept 2005